Summit X, LLC Soligenix, Inc. Transaction History

Summit X, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$1.26 - $2.75 $17,640 - $38,500	-14,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.36 - $2.26 $3,400 - $5,649	2,500 Added 21.74%	14,000 $30,000
Q1 2020 May 13, 2020	SELL	$1.42 - $3.34 $1,420 - $3,340	-1,000 Reduced 8.0%	11,500 $19,000
Q4 2019 Jan 23, 2020	BUY	$0.87 - $1.45 $10,875 - $18,125	12,500 New	12,500 $18,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $146M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.